Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation. [electronic resource]
Producer: 20200520Description: 173-182 p. digitalISSN:- 1877-718X
- Aged
- Antiparkinson Agents -- administration & dosage
- Carbidopa -- administration & dosage
- Drug Combinations
- Drug-Related Side Effects and Adverse Reactions
- Female
- Gels
- Humans
- Infusions, Parenteral
- Levodopa -- administration & dosage
- Male
- Middle Aged
- Parkinson Disease -- drug therapy
- Retrospective Studies
- Severity of Illness Index
- Time Factors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.